UNSPSC 51283716: Cefbuperazone sodium

This classification denotes a cephalosporin antibiotic with the molecular structure C22H28N9O9S2.NA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 1VX59V96BS chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(2-((2,3-dioxo-4-ethyl-1-piperazinyl)formamido)-3-hydroxybutyramido)-7-methoxy- 3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6r-(6-alpha,7-alpha,7(2r*,3s*)))-, but more commonly known as cefbuperazone sodium, which bears US NIH Compound Identifier 127526.

UNSPSC 51283716 Cefbuperazone sodium is a Commodity code for a specific antibiotic pharmaceutical product, but state and local governments have posted no recent solicitations specifically requesting cefbuperazone sodium. The recent opportunities tagged under this code — a piggyback pharmaceutical warehouse contract awarded by the Illinois Department of Public Health for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida procurement for Naloxone and drug deactivation systems — involve different pharmaceuticals entirely and reflect a tagging mismatch rather than actual demand for cefbuperazone sodium. State and local health departments and counties do purchase pharmaceuticals through competitive bidding, cooperative purchasing vehicles, and piggyback contracts, but the recent record does not support active solicitation of cefbuperazone sodium specifically. The Illinois Department of Public Health awarded a $2,999,999.11 multi-year contract through the MMCAP Infuse consortium to Chartwell Rx LLC for antibiotic supply, and Seminole County, Florida issued an IFB on June 30, 2026 for emergency-response pharmaceuticals with annual volumes of 1,900 units of Naloxone and 800 deactivation systems. Neither opportunity involved cefbuperazone sodium.

The code shows little relevant recent activity in state and local procurement. Practitioners tracking state and local pharmaceutical buying should monitor the Family or Class tier above this Commodity code to capture broader antibiotic and pharmaceutical procurement across health departments, counties, and special-purpose districts, since the Commodity-level code itself does not reflect current buying patterns.